Science Explorer Interactive view Map
Company · Vienna · Austria

Nabriva Therapeutics (Austria)

nabriva.comROR OpenAlex
Research works
33
▲ 62% vs 2013–17
Citations
1.3k
37.8 per fractional work
Top-10% rate
8.9%
record average 16.5%
Open access
76%
world 28%

Not ranked overall: Nabriva Therapeutics (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.47× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.24× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 18.76× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 21.23× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.86× its world share, 0 worksChemistryEngineering: 0.30× its world share, 0 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMedicine: 1.54× its world share, 2 worksMedicineVeterinary: 112.88× its world share, 1 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 112.9×. Every wedge is a field page.

Which keywords describe research at Nabriva Therapeutics (Austria)?

By fractional works in all years, weighted toward what it does more of than the world: Antimicrobial Resistance, Brachyspira, Proliferative Enteropathy, Antioxidant, Cancer, Inflammation, Hepatoprotective and Pharmacology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Antimicrobial Resistance11▲ 125×6 topics
  2. Brachyspira9▲ 2302×1 topic
  3. Proliferative Enteropathy9▲ 2302×1 topic
  4. Antioxidant7▲ 30×4 topics
  5. Cancer6▲ 12×4 topics
  6. Inflammation6▲ 7.2×6 topics
  7. Hepatoprotective5▲ 178×2 topics
  8. Pharmacology5▲ 43×2 topics
  9. Epidemiology5▲ 3.5×14 topics
  10. Glycyrrhizin4▲ 321×1 topic
  11. Licorice4▲ 321×1 topic
  12. Cancer Therapy4▲ 17×2 topics
  13. Immunotoxin4▲ 330×1 topic
  14. Ricin Poisoning4▲ 330×1 topic
  15. Healthcare-Associated Infections3▲ 67×2 topics
  16. Clinical Practice Guidelines2▲ 13×2 topics
  17. Vaccine Development2▲ 23×4 topics
  18. Antibiotic-Associated Diarrhea2▲ 250×1 topic
  19. Fecal Microbiota Transplantation2▲ 250×1 topic
  20. Anti-inflammatory2▲ 23×3 topics
  21. Antimicrobial Activity2▲ 31×3 topics
  22. Immune Response2▲ 9.1×2 topics
  23. Genomic Analysis2▲ 17×3 topics
  24. Anticoccidial Drugs2▲ 435×1 topic
  25. Poultry Coccidiosis2▲ 435×1 topic
  26. Antibiotic Resistance1▲ 9.7×7 topics
  27. Immunotherapy1▲ 6.1×3 topics
  28. Treatment1▲ 2.5×5 topics
  29. Anticancer Agents1▲ 12×2 topics
  30. Gene Therapy1▲ 12×3 topics
  31. Humic Substances1▲ 181×1 topic
  32. Nigella sativa1▲ 602×1 topic
  33. Shilajit1▲ 874×1 topic
  34. Thymoquinone1▲ 602×1 topic
  35. Tumor Regression1▲ 34×2 topics
  36. Tumor Targeting1▲ 23×2 topics
  37. Virulence Factors1▲ 16×4 topics

Which research topics does Nabriva Therapeutics (Austria) publish most on?

By volume in 2022–2025: Veterinary medicine and infectious diseases, Cancer Research and Treatments, Toxin Mechanisms and Immunotoxins and Pharmacological Effects of Natural Compounds.

Veterinary medicine and …1Veterinary medicine and infectious diseases: 1 fractional worksCancer Research and Treatments: 1 fractional worksToxin Mechanisms and Imm…1Toxin Mechanisms and Immunotoxins: 1 fractional worksPharmacological Effects …1Pharmacological Effects of Natural Compounds: 1 fractional worksImmunotherapy and Immune Responses: 0 fractional worksNigella sativa pharmacological applications: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksAntibiotics Pharmacokinetics and Efficacy: 0 fractional worksSynthesis and Biological Evaluation: 0 fractional worksCAR-T cell therapy research: 0 fractional works
Small AnimalsBiotechnologyImmunologyPharmacology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Veterinary medicine and infectious diseases Small Animals 1 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 Toxin Mechanisms and Immunotoxins Immunology 1 works
  4. 4 Pharmacological Effects of Natural Compounds Pharmacology 1 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Nigella sativa pharmacological applications Complementary and alternative medicine 0 works
  7. 7 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  8. 8 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  9. 9 Synthesis and Biological Evaluation Organic Chemistry 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available75.6%not open24.4%

World: 28% of research is openly available.

with international co-authors59.8%domestic only40.2%

World: 19% is written across borders.

How has Nabriva Therapeutics (Austria)'s research output changed?

Output in 2018–2022 was 62% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.